Cargando…
Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139949/ https://www.ncbi.nlm.nih.gov/pubmed/34021130 http://dx.doi.org/10.1038/s41419-021-03809-2 |
| _version_ | 1783696093848010752 |
|---|---|
| author | Zhang, Wenda Yu, Wenying Cai, Guiping Zhu, Jiawen Zhang, Chao Li, Shanshan Guo, Jianpeng Yin, Guoping Chen, Chen Kong, Lingyi |
| author_facet | Zhang, Wenda Yu, Wenying Cai, Guiping Zhu, Jiawen Zhang, Chao Li, Shanshan Guo, Jianpeng Yin, Guoping Chen, Chen Kong, Lingyi |
| author_sort | Zhang, Wenda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8139949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81399492021-06-03 Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy Zhang, Wenda Yu, Wenying Cai, Guiping Zhu, Jiawen Zhang, Chao Li, Shanshan Guo, Jianpeng Yin, Guoping Chen, Chen Kong, Lingyi Cell Death Dis Retraction Note Nature Publishing Group UK 2021-05-21 /pmc/articles/PMC8139949/ /pubmed/34021130 http://dx.doi.org/10.1038/s41419-021-03809-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Zhang, Wenda Yu, Wenying Cai, Guiping Zhu, Jiawen Zhang, Chao Li, Shanshan Guo, Jianpeng Yin, Guoping Chen, Chen Kong, Lingyi Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title | Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title_full | Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title_fullStr | Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title_full_unstemmed | Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title_short | Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy |
| title_sort | retraction note to: a new synthetic derivative of cryptotanshinone kyz3 as stat3 inhibitor for triple-negative breast cancer therapy |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139949/ https://www.ncbi.nlm.nih.gov/pubmed/34021130 http://dx.doi.org/10.1038/s41419-021-03809-2 |
| work_keys_str_mv | AT zhangwenda retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT yuwenying retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT caiguiping retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT zhujiawen retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT zhangchao retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT lishanshan retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT guojianpeng retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT yinguoping retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT chenchen retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy AT konglingyi retractionnotetoanewsyntheticderivativeofcryptotanshinonekyz3asstat3inhibitorfortriplenegativebreastcancertherapy |